Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies
This study has been terminated.
Study NCT01416623 Information provided by Jiangsu HengRui Medicine Co., Ltd.
First Received on August 12, 2011. Last Updated on December 20, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Solid Cancer
Interventions listed in this trial
Sponsors listed in this trial
Jiangsu HengRui Medicine Co., Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers